Curevac Nv Stock Current Valuation
| 5CV Stock | EUR 2.72 0.04 1.45% |
Valuation analysis of CureVac NV helps investors to measure CureVac NV's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that CureVac NV's price fluctuation is very steady at this time. Calculation of the real value of CureVac NV is based on 3 months time horizon. Increasing CureVac NV's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CureVac stock is determined by what a typical buyer is willing to pay for full or partial control of CureVac NV. Since CureVac NV is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CureVac Stock. However, CureVac NV's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.72 | Real 2.93 | Hype 2.87 | Naive 2.91 |
The real value of CureVac Stock, also known as its intrinsic value, is the underlying worth of CureVac NV Company, which is reflected in its stock price. It is based on CureVac NV's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CureVac NV's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CureVac NV helps investors to forecast how CureVac stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CureVac NV more accurately as focusing exclusively on CureVac NV's fundamentals will not take into account other important factors: CureVac NV Company Current Valuation Analysis
CureVac NV's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current CureVac NV Current Valuation | 792.23 M |
Most of CureVac NV's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CureVac NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, CureVac NV has a Current Valuation of 792.23 M. This is 94.48% lower than that of the Healthcare sector and 82.95% lower than that of the Biotechnology industry. The current valuation for all Germany stocks is 95.23% higher than that of the company.
CureVac Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CureVac NV's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CureVac NV could also be used in its relative valuation, which is a method of valuing CureVac NV by comparing valuation metrics of similar companies.CureVac NV is currently under evaluation in current valuation category among its peers.
CureVac Fundamentals
| Return On Equity | -0.19 | |||
| Return On Asset | -0.34 | |||
| Profit Margin | (1.26) % | |||
| Operating Margin | (7.27) % | |||
| Current Valuation | 792.23 M | |||
| Shares Outstanding | 221.98 M | |||
| Shares Owned By Insiders | 45.68 % | |||
| Shares Owned By Institutions | 19.07 % | |||
| Price To Book | 2.07 X | |||
| Price To Sales | 13.59 X | |||
| Revenue | 102.99 M | |||
| Gross Profit | (135.09 M) | |||
| EBITDA | (386.49 M) | |||
| Net Income | (411.72 M) | |||
| Cash And Equivalents | 1.33 B | |||
| Cash Per Share | 7.34 X | |||
| Total Debt | 55.28 M | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 5.61 X | |||
| Book Value Per Share | 3.29 X | |||
| Cash Flow From Operations | (733.13 M) | |||
| Earnings Per Share | (0.63) X | |||
| Target Price | 72.97 | |||
| Number Of Employees | 764 | |||
| Beta | 2.93 | |||
| Market Capitalization | 1.85 B | |||
| Total Asset | 1.16 B | |||
| Z Score | 19.8 | |||
| Net Asset | 1.16 B |
About CureVac NV Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CureVac NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CureVac NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CureVac NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CureVac Stock
When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in CureVac Stock please use our How to Invest in CureVac NV guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.